Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M10,402Revenue $M576Net Margin (%)-4.9Z-Score12.5
Enterprise Value $M10,129EPS $0.2Operating Margin %-14.1F-Score2
P/E(ttm))0Cash Flow Per Share $0.0Pre-tax Margin (%)-2.3Higher ROA y-yN
Price/Book7.310-y EBITDA Growth Rate %0Quick Ratio6.3Cash flow > EarningsY
Price/Sales16.85-y EBITDA Growth Rate %0Current Ratio6.7Lower Leverage y-yN
Price/Cash Flow725y-y EBITDA Growth Rate %-1.5ROA % (ttm)-2.0Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-2.8Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M148ROI % (ttm)-2.4Gross Margin Increase y-yN

Gurus Latest Trades with ALKS

Number of guru portfolios checked: 85. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ALKSKen Fisher 2014-09-30 Add$41.54 - $51.52
($44.73)
$ 71.2359%Add 75.86%97,264
ALKSVanguard Health Care Fund 2014-06-30 Add0.13%$41.1 - $50.94
($46.06)
$ 71.2355%Add 18.45%6,135,913
ALKSKen Fisher 2014-06-30 Buy 0.01%$41.1 - $50.94
($46.06)
$ 71.2355%New holding, 55309 sh.55,309
ALKSJohn Burbank 2014-06-30 Sold Out -0.01%$41.1 - $50.94
($46.06)
$ 71.2355%Sold Out0
ALKSVanguard Health Care Fund 2014-03-31 Add0.19%$40.07 - $53.82
($47.32)
$ 71.2350%Add 41.07%5,180,238
ALKSJohn Burbank 2014-03-31 Buy 0.01%$40.07 - $53.82
($47.41)
$ 71.2350%New holding, 4651 sh.4,651
ALKSVanguard Health Care Fund 2013-12-31 Add0.1%$30.17 - $41.12
($36.93)
$ 71.2393%Add 28.18%3,672,087
ALKSVanguard Health Care Fund 2013-09-30 Add0.07%$28.66 - $35.35
($32.58)
$ 71.23119%Add 26.21%2,864,896
ALKSJoel Greenblatt 2013-09-30 Sold Out -0.03%$28.66 - $35.35
($32.58)
$ 71.23119%Sold Out0
ALKSVanguard Health Care Fund 2013-06-30 Add0.11%$22.35 - $33.72
($29.15)
$ 71.23144%Add 84.09%2,269,902
ALKSJoel Greenblatt 2013-06-30 Buy 0.03%$22.35 - $33.72
($29.15)
$ 71.23144%New holding, 26624 sh.26,624
ALKSVanguard Health Care Fund 2013-03-31 Add0.04%$18.52 - $23.81
($21.87)
$ 71.23226%Add 47.24%1,233,024
ALKSVanguard Health Care Fund 2012-03-31 Buy 0.07%$16.14 - $19.5
($16.48)
$ 71.23332%New holding, 787900 sh.787,900
ALKSJohn Burbank 2012-03-31 Sold Out -0.23%$16.14 - $19.5
($16.48)
$ 71.23332%Sold Out0
ALKSDaniel Loeb 2010-06-30 Sold Out -0.92%$10.7 - $13.75
($12.33)
$ 71.23478%Sold Out0
ALKSDaniel Loeb 2010-03-31 Buy 0.92%$9.41 - $14.01
($11.62)
$ 71.23513%New holding, 1000000 sh.1,000,000
ALKSGeorge Soros 2010-03-31 Sold Out $9.41 - $14.01
($11.62)
$ 71.23513%Sold Out0
ALKSJean-Marie Eveillard 2010-03-31 Sold Out -0.01%$9.41 - $14.01
($11.62)
$ 71.23513%Sold Out0
ALKSGeorge Soros 2009-12-31 Buy $7.58 - $9.88
($8.72)
$ 71.23717%New holding, 22800 sh.22,800
ALKSDaniel Loeb 2009-12-31 Sold Out -0.37%$7.58 - $9.88
($8.72)
$ 71.23717%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ALKS is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
ALKS Ken Fisher 2014-12-31107,1640.070.01+10.18%
ALKS Vanguard Health Care Fund 2014-12-316,226,3834.210.86+0.05%
Premium Most recent portfolio changes are included for Premium Members only!


ALKS: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Cooke ShanePresident, Alkermes plc 2015-02-23Sell18,000$74.29-4.37view
Ehrich ElliotSVP, R&D & CMO, Alkermes, Inc. 2015-02-17Sell18,000$70.870.24view
FRATES JAMES MSVP & CFO, Alkermes plc 2015-02-03Sell10,000$70.830.3view
Pugh Gordon GSVP, COO & CRO, Alkermes, Inc. 2015-02-02Sell15,000$72.01-1.35view
BREYER ROBERT ADirector 2015-02-02Sell5,000$72.91-2.56view
Pugh Gordon GSVP, COO & CRO, Alkermes, Inc. 2015-01-26Sell15,000$70.021.46view
Cooke ShanePresident, Alkermes plc 2015-01-23Sell118,000$69.132.76view
BLOOM FLOYD EDirector 2015-01-16Sell20,000$67.125.84view
FRATES JAMES MSVP & CFO, Alkermes plc 2015-01-15Sell10,000$66.866.25view
Ehrich ElliotSVP, R&D & CMO, Alkermes, Inc. 2015-01-15Sell18,375$66.456.91view

Press Releases about ALKS :

Quarterly/Annual Reports about ALKS:

News about ALKS:

Articles On GuruFocus.com
wait for positive ea Apr 06 2013 
comment on ALKS Mar 09 2013 
Best Health Care Investor Edward Owens Buys One New Health Care Stock in First Quarter Apr 30 2012 
Weekly CEO Sells Highlight: Herbalife, CNO Financial Group, Alkermes plc, and TransDigm Oct 08 2011 
Alkermes Inc. Reports Operating Results (10-Q) Feb 03 2011 
Weekly Guru Bargains Highlights: SKX, VRX, ALKS, DF, SVU Dec 05 2010 
Alkermes Inc. Reports Operating Results (10-Q) Nov 04 2010 
Alkermes Inc. Reports Operating Results (10-K) May 21 2010 
Alkermes Inc. Reports Operating Results (10-Q) Feb 04 2010 
Opportunistic Coat-tailing Jan 05 2010 


More From Other Websites
Biotech Stock Roundup: Pharmacyclics Up on Buyout Rumors, Celgene Drug Label Expanded - Analyst Blog Feb 26 2015
Alkermes Falls on Pipeline News; Q4 Earnings Plunge Y/Y - Analyst Blog Feb 25 2015
Alkermes’ Corporate Presentation to be Webcast at the Cowen and Company 35th Annual Health Care... Feb 24 2015
Alkermes’ Corporate Presentation to be Webcast at the Cowen and Company 35th Annual Health Care... Feb 24 2015
Alkermes’ Corporate Presentation to be Webcast at the Cowen and Company 35th Annual Health Care... Feb 24 2015
Alkermes shares down after it stops development of pain pill Feb 24 2015
Alkermes beats Street 4Q forecasts Feb 24 2015
Alkermes beats Street 4Q forecasts Feb 24 2015
Jim Cramer: Use Share Weakness to Buy Alkermes for Its Drug Pipeline Feb 24 2015
Waiting for Yellen Q&A, but QE helping elsewhere Feb 24 2015
Alkermes Plc Earnings Call scheduled for 8:30 am ET today Feb 24 2015
Alkermes To Discontinue Development of Pain Treatment Feb 24 2015
Alkermes plc Reports Financial Results for the Year Ended Dec. 31, 2014 and Provides Financial... Feb 24 2015
ALKERMES PLC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Feb 24 2015
Q4 2014 Alkermes Plc Earnings Release - Before Market Open Feb 24 2015
Alkermes Announces Results From Phase 1 Study of ALKS 7106 Feb 24 2015
Alkermes plc Reports Financial Results for the Year Ended Dec. 31, 2014 and Provides Financial... Feb 24 2015
Alkermes plc Reports Financial Results for the Year Ended Dec. 31, 2014 and Provides Financial... Feb 24 2015
Alkermes Announces Results From Phase 1 Study of ALKS 7106 Feb 24 2015
Alkermes Announces Results From Phase 1 Study of ALKS 7106 Feb 24 2015

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK